- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03656016
Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There are several disorders such as communicating and non- communicating hydrocephalus, normal pressure hydrocephalus, cystic cerebrospinal fluid collections, Chiari malformation, syringomyelic cyst and arachnoid cyst that can change the cerebrospinal fluid dynamics.
Rapid advances in imaging techniques have remarkably improved the diagnosis and treatment of these disorders.
Phase contrast magnetic resonance imaging is a rapid, simple and non-invasive technique which is sensitive to even small cerebrospinal fluid flows, and can be used to evaluate cerebrospinal fluid flow both qualitatively and quantitatively. Cine phase contrast magnetic resonance images show cerebrospinal fluid flow in a dynamic, more easily appreciable, and in a more pleasing manner, allowing the delineation of obstruction, if present, along the portions of cerebrospinal fluid pathway where obstruction is common.
Phase contrast magnetic resonance imaging can be used to discriminate between communicating hydrocephalus and non-communicating hydrocephalus, to localize the level of obstruction in obstructive hydrocephalus, to determine whether arachnoid cysts communicate with the subarachnoid space, to differentiate between arachnoid cysts and subarachnoid space, to discriminate between syringomyelia and cystic myelomalacia, and to evaluate flow patterns of posterior fossa cystic malformations.
This imaging method can also provide significant information in pre-operative evaluation of Chiari 1 malformation and post-operative follow-up of patients with neuroendoscopic third ventriculostomy and ventriculoperitoneal shunt.
The application of cine phase contrast magnetic resonance imaging technique in patients with normal pressure hydrocephalus holds great promise for improvement of the diagnosis, especially in those cases where the differentiation from atrophy on clinical and conventional radiological basis is difficult.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Mostafa Hussein
- Phone Number: 01122999878
- Email: thabet.mostafa@yahoo.com
Study Contact Backup
- Name: Hazem Youseif
- Phone Number: 01005075888
- Email: bozaidhazz@yahoo.com
Study Locations
-
-
-
Assiut, Egypt, 71111
- Recruiting
- Faculty of medicine
-
Contact:
- Mostafa Thabet, MD
- Phone Number: 01122999878
- Email: thabet.mostafa@yahoo.com
-
Contact:
- Marwa Ahmed, MD
- Phone Number: 01006541595
- Email: drmarwa201198@ymail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with different age groups and both sex with clinical and routine conventional magnetic resonance imaging findings suggestive of cerebrospinal fluid flow disorders.
Exclusion Criteria:
- Patients with contraindications for MRI, e.g. an implanted magnetic device, pacemakers or claustrophobia.
- Patients with VP shunts
- Patients with ventriculomegally due to brain SOLs.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
study group
patients with congenital and acquired disorders that can alter the CSF dynamics will undergo phase-contrast magnetic resonance imaging
|
Phase contrast magnetic resonance imaging technique
|
|
control group
age matched healthy individuals will undergo phase-contrast magnetic resonance imaging
|
Phase contrast magnetic resonance imaging technique
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To calculate different cerebrospinal fluid flow parameters at different levels of flow quantification.
Time Frame: base line
|
measure Systolic stroke volume and Peak systolic velocity at different levels of flow quantification
|
base line
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To correlate these parameters to the normal values of age matched control group
Time Frame: baseline
|
correlate Systolic stroke volume and Peak systolic velocity with normal values
|
baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Shimaa Bakr, MSc, Assiut University
Publications and helpful links
General Publications
- Sakka L, Coll G, Chazal J. Anatomy and physiology of cerebrospinal fluid. Eur Ann Otorhinolaryngol Head Neck Dis. 2011 Dec;128(6):309-16. doi: 10.1016/j.anorl.2011.03.002. Epub 2011 Nov 18.
- Yildiz H, Yazici Z, Hakyemez B, Erdogan C, Parlak M. Evaluation of CSF flow patterns of posterior fossa cystic malformations using CSF flow MR imaging. Neuroradiology. 2006 Sep;48(9):595-605. doi: 10.1007/s00234-006-0098-8. Epub 2006 Jun 3.
- Yamada S, Tsuchiya K, Bradley WG, Law M, Winkler ML, Borzage MT, Miyazaki M, Kelly EJ, McComb JG. Current and emerging MR imaging techniques for the diagnosis and management of CSF flow disorders: a review of phase-contrast and time-spatial labeling inversion pulse. AJNR Am J Neuroradiol. 2015 Apr;36(4):623-30. doi: 10.3174/ajnr.A4030. Epub 2014 Jul 10.
- Parkkola RK, Komu ME, Aarimaa TM, Alanen MS, Thomsen C. Cerebrospinal fluid flow in children with normal and dilated ventricles studied by MR imaging. Acta Radiol. 2001 Jan;42(1):33-8. doi: 10.1080/028418501127346431.
- Ng SE, Low AM, Tang KK, Lim WE, Kwok RK. Idiopathic normal pressure hydrocephalus: correlating magnetic resonance imaging biomarkers with clinical response. Ann Acad Med Singap. 2009 Sep;38(9):803-8.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CSFFPCMRI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cerebrospinal Fluid
-
Universitaire Ziekenhuizen KU LeuvenRecruitingCerebrospinal FluidBelgium
-
Wake Forest University Health SciencesCompletedCerebrospinal Fluid ShuntsUnited States
-
The Cleveland ClinicCompletedCerebrospinal Fluid Drainage Catheter
-
First People's Hospital of ChenzhouNot yet recruiting
-
Poitiers University HospitalCompletedCerebrospinal Fluid | Healthy Subjects or VolunteersFrance
-
Yi Feng, MDUnknownAged | Flurbiprofen Axetil | Anesthesia, Spinal | Cerebrospinal FluidChina
-
University of ZurichCompletedCerebrospinal Fluid LeakageSwitzerland
-
Integra LifeSciences CorporationMedtronic - MITGCompletedCerebrospinal Fluid Leakage, SubduralUnited States
-
University of North Carolina, Chapel HillUNC Medical AlumniCompletedCerebrospinal Fluid DrainageUnited States
-
Top Health S.A.P.I DE C.V.CLINICAL RESEARCH PS MEXICOTerminatedCerebrospinal Fluid LeakageMexico
Clinical Trials on Magnetic Resonance Imaging
-
Stanford UniversityTerminatedLaryngeal Neoplasms | Head and Neck Cancers | Larynx CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Healthy SubjectUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Chinese University of Hong KongBeijing Tiantan HospitalRecruitingStroke | Brain Diseases | Ischemic Stroke | Stroke, Ischemic | Stroke, Acute | Stroke Hemorrhagic | Intracerebral Hemorrhage | Stroke (CVA) or TIAHong Kong
-
University of WarwickNorthern Care Alliance NHS Foundation Trust; University Hospitals Coventry... and other collaboratorsUnknown
-
Daniel M. SpielmanNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMalignant Central Nervous System Neoplasm | Metastatic Malignant Neoplasm in the Central Nervous SystemUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedBrain TumorUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedThoracic Spine NeoplasmUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Terminated